P—ERK蛋白在结直肠癌中的表达及意义(3)
![]() |
第1页 |
参见附件。
[2]Seger R,Krebs EG.The MAPK signaling cascade.FASEB J,1995,9(9):726-35.
[3]Hartmann C,Bartels G,et al. PIK3CA mutations in glioblastomamultiform [J]. Acta Neuropathal.2005,109:639-42.
[4]Thompson N,Lyons J.Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery[J].CurrOpin Pharm acol, 2005, 5(4): 350- 356.
[5]Aisa Y,Miyakawa Y, Nakazato T,et al.Fucoidan induces apoptosis of human HS2
sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways.Am J Hem atol,2005,78(1):7-14.
[6]Hoshino R,Chatani Y,Yamori T, et al.Constitutive activition of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors[J]. Oncoge- ne,1999,18(3):813-822.
[7]Mueller H, Flury N,Eppenberger-Castori S, et al.Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients.Int J Cancer,2000, 89(4):384-388.
[8]JIANG Chengying, DAI Guanghai Ras/Raf/Mek/Erk信号传导通路在肝细胞癌发生中的作用机制及在靶向治疗中的应用[J]. 中国肿瘤临床, 2008,35(23):13 77-80.
[9]Schmitz KJ,Wohlschlaeger J,Lang H,Sotiropoulos GC,Malago M,Steveling K, Reis H,Cicinnati VR,Schmid KW, Baba HA, Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol.2008 Jan;48(1):83-90.
[10]江兴松,张南征,王小友 胃癌组织SSTR亚型与P-ERK表达关系的研究[J]. ActaAcademiae Medicinae Xuzhou,2007, 27(4)220-24.
[11]王兵,周士福,蔡凤林,马兆生 PTEN,P-AKT,P-ERK蛋白在胃癌组织中的表达及意义[J]. Modern Oncology 2008,16(9):1568-1570.
[12]孙慧 张静 战忠利等雌激素及雌激素受体拮抗剂对乳腺癌信号传导通路中MEK-2和P-ERK 病理形态的影响[J].中国肿瘤临床,2008,35(4):219-222.
您现在查看是摘要介绍页,详见PDF附件。